![Yi Liu Kai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yi Liu Kai
Direttore/Membro del Consiglio presso Bristol-Myers Squibb FCT bêta, Inc.
Profilo
Yi Liu Kai currently works at Bristol-Myers Squibb FCT bêta, Inc., as Vice Chairman from 2021.
Posizioni attive di Yi Liu Kai
Società | Posizione | Inizio |
---|---|---|
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | 05/11/2021 |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Yi Liu Kai